Cellebrite DI : Investor Presentation May 2026

Published: 2026-05-14 08:06:11 ET CLBT

Published on 05/14/2026 at 08:06 am EDT

May 2026

https://www.cellebrite.com

o 2026 Cellebrite DI Ltd.

Mission

Protect Communities, Nations and Businesses.

Solution

Platform

Comprehensive Solutions for Investigations, Intelligence and Operations.

Solution

Collect

Unlock

Automate

Extract

Lab

Core Capabilities

Field

Solution

Core Capabilities

Store

Case MNGT

Manage

Elaborate Ev dence MNGT

u!nerabiI!ty Res App Security

Automot ve

u!ti-data Source

u!ti-dev ce GenAI

Core Capabilities

Industria Systems Device Rep ication

Virtualize

Solution

Agentic AI

Core Capabilities

↑ Digital Evidence

↑ Case Load (data volumes and cases)

↑ Criminal Technical

Sophistication

↑ Public Scrutiny

Public Safety Gap

o o o

Three Major Challenges

→ Constant crime rate and an increasing population* (leading to higher case load)

→ 97% cite smartphones as the top evidence source**

→ 94% say complexity strains caseloads**

→ Increasing criminal technical sophistication

Public Safety Gap

→ Static case closure rates

→ Skills gap of agency staff

→ Review & analysis consume up to 60% of an investigation, with most reviews still manual**

→ Escalating officer attrition and burnout

Ethics & Accountability

→ Ever-increasing public scrutiny

→ Technology provider focus on data privacy

→ Artificial Intelligence use in Law Enforcement and Criminal Activity

* Real-Time C ime Index

** 2026 Cel!ebrite Industry T ends Survey

Our Customers Care About Time.

Cellebrite Delivers.

Time-to-Data Time-to-Insights Time-to-Collaboration

Time-to-Evidence

Time-to-Justice Time-to-Intelligence Time-to-Action

→ Faster access to more devices. Extraction of more data.

→ Faster examinations. More actionable, high-value information.

→ Greater efficiency and productivity.

→ Faster analysis. A high-fidelity chain of custody.

→ Faster closure of more cases.

→ Faster visibility into device vulnerabilities and application security.

→ Accelerated insights support sharper decisions and decisive action.

SOK IMAGES

AND VIDEO

MILLIONS OF

MESSAGES

60% OF ALL

INTERNET TRAFFIC

OVER 30 COMMUNICATION APPS

10 APPS ACTIVELY USED / DAY

Virtually all crime has a digital component Increasing data volume and complexity limit investigative speed & efficiency

IMAGE CLASSIFICATION & SIMILARITY TOPIC DETECTION

BUILT-IN TRANSLATION

MESSAGE SUMMARIZATION

120 HOURS OFVOCE

10 TO 15 SOCIAL

ACCOUNTS

4.5 HOURS SCREEN

TIME/ DAY

Cellebrite AI

→ LANGUAGE AGNOSTIC

→ MULTIMODAL ANALYSIS

→ NATIVE MEDIA ANALYTICS

→ SCALABILITY

LOCATION CORROBORATION

SPEECH TO TEXT

IDENTITY RESOLUTION

WEB BROWSER HISTORY SUMMARY MULTI-COMMUNICATION PLATFORM ANALYSIS

Digital Witnesses

Terrorism Cybercrime Homicide Narcotics

Child Exploitation Human Trafficking

→ Why

→ Full traceability, ethical use, and human verification

→ Security, Privacy and Chain-of-Custody

→ Legal, Forensics and

Regulatory Standards

→ Proprietary Data Access & Extraction

Other Evidentiary Artifacts

Cell Towers Case Records License Plates OSINT Ballistics Testimonials

Leadership Counterterrorism Unit Regional Police Force (APAC)

Detective

County Sheriff's Office (USA)

May 2026

Example 01

U.S. National Law Enforcement Agency

•

Extract

Decode

Automate

Lab

Field

Store

Collaborate

Evidence MNGT.

Case MNGT.

Current Solution

Future Expansion

Unlock

Core Capabilities

Multi-device

Multi-data Source

GenAI

Agentic AI

Example 02

EMEA: Defense & Intelligence Customer

Unlock

Extract

Decode

Lab

Solution

Core Capabilities

Example 03

U.S. SLG: County-Level DA Office

Extract

Decode

Lab

Store

Case MNGT.

Multi-data Source

GenAI

Agentic AI

Solution

Unlock

Core Capabilities

Example 04

EMEA: National Law Enforcement Agency

Extract

Decode

Lab

Field

Vulnerability Res.

Solution

Unlock

Core Capabilities

Founded in 2008 →

Acquisition closed in Q126

Cellebrite paid $15M+, net in

cash and issued $1M in RSUs →

Less than $0.5M in acquired ARR

→

May 2026

+21°Zo

ARR: MAR 26

-$• $128M +19°Zs

TOTAL REVENUE: FY26-Q1

-$• $118M +25*/s

SUBSCRIPTION REVENUE: FY26-Q1

-$• â51M 24*/a

Adj. EBITDA & Adj. EBITDA %*: FY26-Q1

Ruie of X

23% 21%

TTM MAR-25 TTM MAR-26

FCF Margin m ARR Growth

* Non-GAA*

Note: non-GAA* met ics and key perfo mance ndicators defined in the apDendix along with a reconci! iation Detween the non-GAAP met ie and its most aDDI›caoIe GAA* measure.

May 2026

https://www.cellebrite.com

o 2026 Cellebrite DI Ltd.

→ MAR-26 ARR grew 21% °"°*•°

â408.1

→ Gross revenue retention -92%

→ Existing customer expansion fuels most of the organic ARR growth

→ Growth products increased -100% and represent -14% of

total ARR MAR-25 MAR-26

→ nseyets conversions approach 60% with an absolute dollar °cuard'an''ath"nder c°re"'umFa "'es Mana'e'A''virtua"

contribution in line with recent prior 1 2-month periods 'nse'ets'r°du'tFam* c"e't)

ARR BY

GEOGRAPHY $221 $226 $240

($ in millions)

$256 $261

$136 $142 $147

$166 $171

$50 $51 $52 $58 $61

FY25-Q1 FY25-Q2 FY25-Q3 FY25-Q4 FY26-Q1 FY25-Q1 FY25-Q2 FY25-Q3 FY25-Q4 FY26-Q1 FY25-Q1 FY25-Q2 FY25-Q3 FY25-Q4 FY26-Q1

AMERICAS APAC

ARR MIX BY MAR-26 GROWTH: +18% MAR-26 GROWTH: +21%

GEOGRAPHY

NOIR: NUMDCFS Mdy ROI tots! dUQ IO FOU cdi 0@

HEALTHY SOFTWARE GROSS MARGIN

Cost of Goods Sold (Non-GAAP, $M) and Gross Margin (Non-GAAP, %)

85.1%

PRUDENT INVESTMENT

TO SUPPORT GROWTH

Operating Expense (Non-GAAP, $M) and Operating Expense Margin (Non-GAAP, %)

59.7%

84%

85%

85% 86%

86%

64%

62%

56% 58%

64%

FY25-Q1 FY25-Q2 FY25-Q3 FY25-Q4

FY26-Q1

FY25-Q1 FY25-Q2 FY25-Q3 FY25-Q4

FY26-Q1

Note: non-GAA* met ics and key perfo mance indicators defined in the apDendix along with a reconci!iatiOn Detween the non-GAA* metric and its most aDDIicab!e GAAP measu e.

CASH & INVESTMENTS

($ in millions)

$483.8 $535.0

$534.6

$331.8

$205.7

FY 22

Cash & Cash Equivalents

Note: Numbers may not tata! due to rounding

FY 23

FY 24 FY25

Short-Term & Long-Term Marketable Securities

FY26-Q1

m Deposits

$ in millions

31.9%

32.0%

27.4%

13.6%

TTM 3/31/2023

TTM 3/31/2024

TTM 3/31/2025

TTM 3/31/2026

SEASONALLY STRONGER 2H OPERATING PERFORMANCE DRIVES HIGHER FCF MARGIN

1 Defined as cash flow provided by operations less capital expenditures

Note: non-GAAP metrics and key performance indicators defined in the appendix along with a reconciliation between the non-GAAP metric and its most applicable GAAP measure.

3.5

13.7

7.4

195.7

198.3

200.1

218.3

233.0

238.3

243.0

244.8

245.9

Q1 24

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Opening Balance Company Equity Plans Merger-Related Equity Instruments

May 2026

https://www.cellebrite.com

o 2026 Cellebrite DI Ltd.

FY25

FY26-Q2 FY26

EXPECTATIONS EXPECTATIONS

hws or s/ a/2s) hws or s/‹a/2s)

ARR

$481 M

ARR Growth (y/y)

+21 %

Revenue

$476M

Revenue Growth (y/y)

+19%

Adjusted EBITDA*

$127.6M

Adjusted EBITDA Margin*

26.8%

* Non-GAAP

Note: non-GAA* met ics and key perfo mance ndicators defined in the aDpendix along with a econciIiation between the non-GAA* met ie and its mOst aDD!icaDie GAAP measure

→ A healthy market with powerful tailwinds

→ Purpose-built technology elevates productivity, efficiency and impact in public safety

→ End-to-end platform

→ Al-powered and cloud-ready solutions

→ Increasing wallet share with diverse, global customer base

→ Rule of X(ARR growth rate + FCF margin) performance objective of 50+

→ Firepower accelerate innovation and TAM expansion

Protecting Communities, Businesses and Nations

This presentation includes non-GAAP financial measures. Cellebrite believes that the use of non-GAAP cost of revenue, non-GAAP gross profit, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating income margin, non-GAAP net income, non-GAAP EPS, adjusted EDITDA and adjusted EBITDA margin, free cash flow and free cash flow margin is helpful to investors. These measures, which the Company refers to as our non-GAAP financial measures, are not prepared in accordance with GAAP.

The Company believes that the non-GAAP financial measures provide a more meaningful comparison of its operational performance from period to period, and offer investors and management greater visibility to the underlying performance of its business. Mainly:

Share-based compensation expenses utilize varying available valuation methodologies, subjective assumptions and a variety of equity instruments that can impact a company's non-cash

expenses;

Acquired intangible assets are valued at the time of acquisition and are amortized over an estimated useful life after the acquisition, and acquisition-related expenses are unrelated to current operations

and neither are comparable to the prior period nor predictive of future results;

To the extent that the above adjustments have an effect on tax (income) expense, such an effect is excluded in the non-GAAP adjustment to net income;

Tax expense, depreciation and amortization expense vary for many reasons that are often unrelated to our underlying performance and make period-to-period comparisons more challenging; and

Financial instruments are remeasured according to GAAP and vary for many reasons that are often unrelated to the Company's current operations and affect financial income.

Free cash flow is calculated as net cash provided by or used in operating activities less purchases of property and equipment and capitalized internal-use software. We believe that free cash flow is a useful indicator of liquidity that provides information to management and investors about the amount of cash provided by or used in our operations that, after the investments in property and equipment, can be used for strategic initiatives.

Each of our non-GAAP financial measures is an important tool for financial and operational decision making and for evaluating our own operating results over different periods of time. The non-GAAP financial measures do not represent our financial performance under U.S. GAAP and should not be considered as alternatives to operating income or net income or any other performance measures derived in accordance with GAAP. Non-GAAP measures should not be considered in isolated from, or as an alternative to, financial measures determined in accordance with GAAP. Non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, and exclude expenses that may have a material impact on our reported financial results. Further, share-based compensation expense has been, and will continue to be for the foreseeable future, significant recurring expenses in our business and an important part of the compensation provided to our employees. In addition, the amortization of intangible assets is expected recurring expense over the estimated useful life of the underlying intangible asset and acquisition-related expenses will be incurred to the extent acquisitions are made in the future. Furthermore, foreign exchange rates may fluctuate from one period to another, and the Company does not estimate movements in foreign currencies.

A reconciliation of each of these non-GAAP financial measures to their most comparable GAAP measure is set forth in a table included at the end of this presentation, which is also available on our website at https://investors.Cellebrite.com.

In regard to forward-looking non-GAAP guidance, we are not able to reconcile the forward-looking Adjusted EBITDA measure to the closest corresponding GAAP measure without unreasonable efforts because we are unable to predict the ultimate outcome of certain significant items including, but not limited to, fair value movements, share-based payments for future awards, tax expense, depreciation and amortization expense, and certain financing and tax items.

Quarter Ended

31-Mar 30-Jun 30-Sep 31-Dec

408,060

-408,060

418,875

439,803

480,760

16,078

464,682

$ 408,060 $ 418,875 $ 439,803 $ 480,760

221,259 226,296 240,244 256,380

136,432 141,762 147,200 166,440

50,369 50,817 52,359 57,940

121%

120%

117%

116%

480,760

16,078

464,682

$ 480,760

256,380

166,440

57,940

116%

Yr Ended 31-Dec

395,899

-395,899

$ 395,899

214,565

134,061

47,273

124%

Yr Ended 31-Dec

315,689

$ 315,689

165,389

114,206

36,094

125%

Yr Ended 31-Dec

FY 2025

FY 2024

FY 2023

FY 2026

Cellebrite DI Ltd. - Revenue Mix

(U.S. Dollars in thousands - unaudited)

Quarter Ended

31-Dec

Annual recurring revenue

Total ARR

ARR related to acquisitions Organic ARR

492,970

-492,970

Annual recurring revenue

America EMEA APAC

$ 492,970

261,090

170,930

60,950

Recurring revenue net dollar-based retention rate 114%

Note: This document should be read in conjunction with the Company's SEC Filings.

FY 2025

FY 2024

FY 2023

FY 2026

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP cost of revenue: Cost of revenue Less:

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP cost of revenue

GAAP gross profit:

Gross profit

Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP gross profit

Quarter Ended

Yr Ended 31-Dec

$ 53,231

1,733

-52

$ 51,446

$271,879

1,733

-52

$273,664

Yr Ended 31-Dec

$ 62,593

2,227

-2

$ 60,364

$ 338,610

2,227

-2

$ 340,839

31-Mar 30-Jun 30-Sep 31-Dec

$ 17,490 $ 17,677 $ 20,314 $ 19,691

750 827 828 775

- - - 881

- - - -

$ 16,740 $ 16,850 $ 19,486 $ 18,035

$ 90,059 $ 95,599 $ 105,715 $ 109,130

750 827 828 775

- - - 881

- - - -

$ 90,809 $ 96,426 $ 106,543 $ 110,786

Quarter Ended

Yr Ended 31-Dec

$ 75,172

3,180

881

$ 71,111

$ 400,503

3,180

881

$ 404,564

31-Mar

$ 22,420

692

3,612

$ 18,116

$ 105,881

692

3,612

$ 110,185

FY 2025

FY 2024

FY 2023

FY 2026

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP operating expenses: Operating expenses Less:

Executive severance costs Issuance expenses

Dividend participation compensation Share-based compensation expense

Amortization of intangible assets Acquisition-related costs

Capital loss from FA disposal

Non-GAAP operating expenses

GAAP operating income (loss) Executive severance costs Issuance expenses

Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition-related costs

Non-GAAP operating income (loss)

Quarter Ended

Yr Ended 31-Dec

$ 281,704

1,068

28,348

3,349

219

$ 248,720

$ 56,906

1,068

-30,575

3,349

221

$ 92,119

31-Mar 30-Jun 30-Sep 31-Dec

$ 77,791 $ 81,182 $ 86,725 $ 88,325

- -

- - 574 -

- - - -

8,027 7,983 14,480 11,222

926 931 934 1,227

- 2,066 164 1,588

- - - -

$ 68,838 $ 70,202 $ 70,573 $ 74,288

$ 12,268 $ 14,417 $ 18,990 $ 20,805

- - 574 -

- - - -

8,777 8,810 15,308 11,997

926 931 934 2,108

- 2,066 164 1,588

$ 21,971 $ 26,224 $ 35,970 $ 36,498

Quarter Ended

Yr Ended 31-Dec

$ 334,023

574

41,712

4,018

3,818

$ 283,901

$ 66,480

574

-44,892

4,899

3,818

$ 120,663

31-Mar

$ 96,762

-13,692

1,362

109

$ 81,599

$ 9,119

-14,384

4,974

109

$ 28,586

Yr Ended 31-Dec

$238,642

-(345)

-17,265

3,347

(7)

$218,382

$ 33,237

-(345)

-18,998

3,347

$ 55,282

FY 2026

FY 2025

FY 2024

FY 2023

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

GAAP net income (loss) Executive severance costs Issuance expenses

Share-based compensation expense Amortization of intangible assets Acquisition related costs

Income tax expense Finance expenses (income)

Non-GAAP net income (loss)

GAAP net income (loss) Financial (Income) expense Tax expense (income)

Depreciation and amortization Executive severance costs Issuance expenses

Share-based compensation expense Acquisition-related costs

Adjusted EBITDA

Adjusted EBITDA margin

Quarter Ended

Yr Ended 31-Dec

$ (81,100)

-(345)

18,998

3,347

633

119,348

$ 60,926

$ (81,100)

108,800

5,537

10,011

(345)

18,998

$ 61,946

19.1%

Yr Ended 31-Dec

$ (283,007)

1,068

-30,575

3,349

221

(4,049)

349,604

$ 97,761

$ (283,007)

332,890

7,023

10,607

1,068

-30,575

221

$ 99,377

24.8%

31-Mar 30-Jun 30-Sep 31-Dec

$ 17,400 $ 19,476 $ 20,189 $ 21,261

- - 574 -

- - - -8,777 8,810 15,308 11,997

926 931 934 2,108

- 2,066 164 1,588

(924) (510) (309) (260)

- - - -

$ 26,179 $ 30,773 $ 36,860 $ 36,694

$ 17,400 $ 19,476 $ 20,189 $ 21,261

(7,060) (6,374) (5,298) (5,466)

1,928 1,315 4,099 5,010

2,631 2,592 2,703 3,941

- - 574 -

- - - -8,777 8,810 15,308 11,997

- 2,066 164 1,588

$ 23,676 $ 27,885 $ 37,739 $ 38,331

22.0% 24.6% 29.9% 29.8%

Quarter Ended

Yr Ended 31-Dec

$ 78,326

574

-44,892

4,899

3,818

(2,003)

$ 130,506

$ 78,326

(24,198)

12,352

11,867

574

-44,892

3,818

$ 127,631

26.8%

31-Mar

$ 10,938

-14,384

4,974

109

215

$ 30,620

$ 10,938

(4,515)

2,696

7,005

-14,384

109

$ 30,617

23.9%

FY 2025

FY 2024

FY 2023

FY 2026

GAAP to Non-GAAP Reconciliations

(U.S. Dollars in thousands, except share and per share data)

Cash flows from operating activities

Less:

Purchase of property and equipment

Free Cash Flow

Free Cash Flow margin

Quarter Ended

Yr Ended 31-Dec

102,058

(5,231)

$ 96,827

29.8%

Yr Ended 31-Dec

132,171

(8,566)

$ 123,605

30.8%

31-Mar 30-Jun 30-Sep 31-Dec 20,878 32,583 33,272 86,811

(2,339) (3,608) (3,322) (3,956)

$ 18,539 $ 28,975 $ 29,950 $ 82,855

17.2% 25.6% 23.8% 64.3%

Quarter Ended

Yr Ended 31-Dec

173,544

(13,225)

$ 160,319

33.7%

31-Mar 19,885

(3,041)

$ 16,844

13.1%

FY22-Q2

FY22-Q3

FY22-Q4

FY23-Q1

TTM 3/31/2023

$ (4,073)

$ (556)

$ 35,743

$ 12,476

$ 43,590

$ (1,571)

$ (1,630)

$ (1,391)

$ (1,064)

$ (5,656)

$ (5,644)

$ (2,186)

$ 34,352

$ 11,412

$ 37,934

-9.0%

-3.0%

46.4%

16.0%

13.6%

FY23-Q2

FY23-Q3

FY23-Q4

FY24-Q1

TTM 3/31/2024

$ 16,576 $ 29,178 $ 43,828 $ 10,041

$ 99,623

$ (825) $ (1,082) $ (2,260) $ (1,495)

$ (5,662)

$ 15,751

$ 28,096

$ 41,568

$ 8,546

$ 93,961

20.5%

33.4%

44.7%

9.5%

27.4%

Cash flows from operating activities

Less:

Purchase of property and equipment

Free Cash Flow

FY24-Q2 FY24-Q3

FY24-Q4

FY25-Q1

TTM 3/31/2025

$ 14,513 $ 41,650

$ 65,967

$ 20,878

$ 143,009

$ (2,073) $ (1,820)

$ (3,178)

$ (2,339)

$ (9,410)

$ 12,440 $ 39,830

$ 62,789

$ 18,539

$ 133,599

13.0% 37.3%

57.6%

17.2%

31.9%

Free Cash Flow margin

FY25-Q2

FY25-Q3

FY25-Q4

FY26-Q1

TTM 3/31/2026

Cash flows from operating activities

$ 32,582

$ 33,272

$ 86,811

$ 19,885

$ 172,550

Less:

Purchase of property and equipment

$ (3,608)

$ (3,322)

$ (3,956)

$ (3,041)

$ (13,927)

Free Cash Flow

$ 28,974

$ 29,950

$ 82,855

$ 16,844

$ 158,623

Free Cash Flow margin

25.6%

23.8%

64.3%

13.1%

32.0%

→ Annual Recurring

Revenue

Annual recurring revenue (ARR) is defined as the annualized value of active term-based subscription license contracts and maintenance contracts related to perpetual licenses in effect at the end of that period. Subscription license contracts and maintenance contracts for perpetual licenses are annualized by multiplying the revenue of the last month of the period by 12.

→ Subscription Revenue

Is defined as revenue from recurring, term-based license contracts and ongoing services related to core offerings. Subscription revenue is recognized ratably over the subscription term with a portion of revenue, related to the term-based license, recognized upfront.

'*:**Cellebrite

END-TO-END

PLATFORM

FOR DIGITAL INVESTIGATIONS & INTELLIGENCE

$493M ARR (3/31/26)

-7,00O Global Customers

-PM Serious crime legally-sanctioned investigations in 2025*

Solution for digital forensic examiners

1,271 Employees (3 31 26)

Based on interna research estimates

World-Class

Sector

3000+

50/50

20/20

15/20*

Private ctor

72/100

10/10

9/10

Customer Base

North American state and local accounts

U.S. states

Police deDartments in tne 20 largest U.S. cities

Largest EuroDean Dolice deDartments

of The Fortune 100

of Top 10 accounting firms

ofTopl0 U.S. commer abanKs

100+

27/27

8/10

U.S. caDinet

executive deDartments

North American federal accounts

MemDer E.U. national Dolice

of ToD 10

Dharma comDanies

ofTopl0 U.S. ehnologycompnies

roes that Cel eb ite does not act ve y part› p a!, ethical and bus ness cons derations.

'...- Cellebrite

We've established our global footprint with meaningful room for expansion across our installed customer base

Public Sector

→ Law Enforcement

→ Defense & Intelligence

Private Sector

→ Enterprises

→ Service Providers

IMPROVED RETENTION

NEW

LOGOS

VIRTUALIZE

(Corellium)

MANAGE & AI

(Guardian, Genesis & Pathfinder)

COLLECT

(Inseyets)

May 2026

https://www.cellebrite.com

o 2026 Cellebrite DI Ltd.

Disclaimer

Cellebrite DI Ltd. published this content on May 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 14, 2026 at 12:05 UTC.